Carregant...
Qualitative and quantitative measures of various compounded formulations of 17-hydroxyprogesterone caproate
OBJECTIVES: 17-hydroxyprogesterone caproate (17-OHPC) is available both as an FDA – approved medication and as a product prepared for individual patients by compounding pharmacies. Compounding pharmacies may omit the preservative used in the FDA approved formulation or use an alternate preservative...
Guardat en:
| Autors principals: | , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2013
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3672260/ https://ncbi.nlm.nih.gov/pubmed/23453884 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ajog.2013.02.028 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|